Euroapi: financing finalised for FOCUS-27 plan

(CercleFinance.com) - As part of its strategic roadmap, Euroapi has finalised and secured financing for its FOCUS-27 strategic plan, and signed with Sanofi a new amendment to the global manufacturing and supply contract signed in 2021.


The group has thus signed with its banking syndicate a new E451m secured revolving credit facility (RCF), which refinances the existing revolving credit facility, with a maturity extended to February 2029.

Sanofi will also invest E200m in a super-subordinated perpetual hybrid bond, which carries a coupon of 8.113% until the first reset date, scheduled for February 2029.

Finally, Sanofi has agreed to reserve minimum available capacity for five selected products manufactured by Euroapi. The healthcare group will thus pay E54m, including E18m in H2 2024 and E36m in 2025.


Copyright (c) 2024 CercleFinance.com. All rights reserved.